Andrew Hope
Affiliations: | Radiation Oncology | Washington University School of Medicine, St. Louis, MO, United States |
Google:
"Andrew Hope"Cross-listing: E-Tree
Parents
Sign in to add mentor| Joseph O. Deasy | research assistant | Washington University School of Medicine | ||
| (Andrew "Drew" was a Rad Onc resident who worked with our group.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Chan M, Palma D, Barry A, et al. (2021) Practical Considerations for the Implementation of a Stereotactic Body Radiation Therapy Program for Oligo-Metastases. Advances in Radiation Oncology. 6: 100499 |
| Atallah S, Le LW, Bezjak A, et al. (2020) Validating impact of pretreatment tumor growth rate on outcome of early-stage lung cancer treated with stereotactic body radiation therapy. Thoracic Cancer |
| Hosni A, Chiu K, Hui Huang S, et al. (2020) Non-operative management for oral cavity carcinoma: definitive radiation therapy as a potential alternative treatment approach. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology |
| McDowell L, So N, Keshavarzi S, et al. (2020) Sexual satisfaction in nasopharyngeal carcinoma survivors: Rates and determinants. Oral Oncology. 109: 104865 |
| Liu T, David M, Batstone M, et al. (2020) The utility of postoperative radiotherapy in intermediate-risk oral squamous cell carcinoma. International Journal of Oral and Maxillofacial Surgery |
| de Almeida JR, Truong T, Khan NM, et al. (2020) Treatment implications of postoperative chemoradiotherapy for squamous cell carcinoma of the oral cavity with minor and major extranodal extension. Oral Oncology. 110: 104845 |
| Hueniken K, Douglas CM, Jethwa AR, et al. (2020) Measuring financial toxicity incurred after treatment of head and neck cancer: Development and validation of the Financial Index of Toxicity questionnaire. Cancer |
| Huang SH, O'Sullivan B, Su J, et al. (2020) Hypofractionated radiotherapy alone with 2.4 Gy per fraction for head and neck cancer during the COVID-19 pandemic: The Princess Margaret experience and proposal. Cancer |
| Day D, Prawira A, Spreafico A, et al. (2020) Phase I trial of alpelisib in combination with concurrent cisplatin-based chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck. Oral Oncology. 108: 104753 |
| Klement RJ, Sonke JJ, Allgäuer M, et al. (2020) Correlating dose variables with local tumor control in stereotactic body radiotherapy for early stage non-small cell lung cancer: A modelling study on 1500 individual treatments. International Journal of Radiation Oncology, Biology, Physics |